Eligibility and extrapolation in cancer clinical trials.

Suppr

超能文献

作者信息

Begg C B, Engstrom P F

出版信息

J Clin Oncol. 1987 Jun;5(6):962-8. doi: 10.1200/JCO.1987.5.6.962.

DOI:10.1200/JCO.1987.5.6.962

PMID:3585451

Abstract

摘要

相似文献

Eligibility and extrapolation in cancer clinical trials.

J Clin Oncol. 1987 Jun;5(6):962-8. doi: 10.1200/JCO.1987.5.6.962.

[Why is it sometimes necessary to include a large number of patients in clinical trials?].

Bull Cancer. 1989;76(6):569-71.

Letter to the Editor re Yu and Holmgren. Traditional endpoint of progression-free survival (PFS) may not be appropriate for evaluating cytostatic agents combined with chemotherapy in cancer clinical trials.

Contemp Clin Trials. 2007 Sep;28(5):674. doi: 10.1016/j.cct.2007.03.008. Epub 2007 Mar 23.

Adjuvant systemic therapy for resectable breast cancer.

J Clin Oncol. 1985 Feb;3(2):259-75. doi: 10.1200/JCO.1985.3.2.259.

Interpretation of results of chemotherapy trials in metastatic breast cancer.

J Clin Oncol. 1986 Feb;4(2):258-61. doi: 10.1200/JCO.1986.4.2.258.

TAILORx: trial assigning individualized options for treatment (Rx).

Clin Breast Cancer. 2006 Oct;7(4):347-50. doi: 10.3816/CBC.2006.n.051.

Elderly breast cancer patients: adjuvant chemotherapy and adjuvant endocrine therapy.

Gynakol Geburtshilfliche Rundsch. 2005 Jun;45(3):137-42. doi: 10.1159/000085194.

Alternating versus sequential therapy in advanced breast cancer.

Medicina (B Aires). 1987;47(3):243-8.

Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design.

Breast Cancer Res Treat. 2010 Dec;124(3):701-5. doi: 10.1007/s10549-010-1212-5. Epub 2010 Oct 16.

[Importance of the composition of various combination regimens in the chemotherapy of metastatic breast cancer].

Dtsch Med Wochenschr. 1987 Feb 13;112(7):270-5. doi: 10.1055/s-2008-1068044.

引用本文的文献

Exclusion of people from oncology clinical trials based on functional status.

Clin Trials. 2025 Jun;22(3):367-373. doi: 10.1177/17407745241304114. Epub 2025 Jan 2.

Clinical trial recruiters' experiences working with trial eligibility criteria: results of an exploratory, cross-sectional, online survey in the UK.

Trials. 2021 Oct 24;22(1):736. doi: 10.1186/s13063-021-05723-6.

Are clinical trial eligibility criteria an accurate reflection of a real-world population of advanced non-small-cell lung cancer patients?

Curr Oncol. 2018 Aug;25(4):e291-e297. doi: 10.3747/co.25.3978. Epub 2018 Aug 14.

Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications.

Blood Adv. 2018 Jan 23;2(2):116-119. doi: 10.1182/bloodadvances.2017010512.

Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications.

Invest New Drugs. 2017 Dec;35(6):827-833. doi: 10.1007/s10637-017-0510-8. Epub 2017 Sep 14.

Should criteria for inclusion in cancer clinical trials be expanded?

J Comp Eff Res. 2015 Aug;4(4):289-91. doi: 10.2217/cer.15.27.

Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma--Analysis Using Diagnostic Nodes.

Oncologist. 2015 Sep;20(9):1028-35. doi: 10.1634/theoncologist.2015-0145. Epub 2015 Aug 3.

Survival of patients with chronic myelocytic leukemia: comparisons of estimates from clinical trial settings and population-based cancer registries.

Oncologist. 2011;16(5):663-71. doi: 10.1634/theoncologist.2010-0393. Epub 2011 Apr 6.

Processes and outcomes of care for soft tissue sarcoma of the extremities.

Sarcoma. 2002;6(1):19-26. doi: 10.1080/13577140220127521.

Selecting subjects for participation in clinical research: one sphere of justice.

J Med Ethics. 1999 Feb;25(1):31-6. doi: 10.1136/jme.25.1.31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验